Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: Modulation by tacrolimus

被引:27
作者
Morelli, AE
Antonysamy, MA
Takayama, T
Hackstein, H
Chen, ZY
Qian, SG
Zurowski, NB
Thomson, AW
机构
[1] Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Dept Mol Genet & Biochem, Pittsburgh, PA 15213 USA
关键词
D O I
10.4049/jimmunol.165.1.226
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Flt3 ligand (FL) is a potent hemopoietic growth factor that strikingly enhances stem tells and dendritic cells (DC) in vivo. We examined the impact of infusing FL-mobilized bone marrow (BM) cells on microchimerism and anti-donor reactivity in normal and tacrolimus-immunosuppressed, noncytoablated allogeneic recipients, BM from B10 (H2(b)) mice given FL (10 mu g/day; days 0-8; FL-BM) contained a 7-fold higher incidence of potentially tolerogenic immature CD11c(+) DC (CD40(low), CD80(low), CD86(low), MHC IIlow) that induced alloantigen-specific T cell hyporesponsiveness in vitro. C3H (H2(k)) mice received 50 x 10(6) normal or FL-BM cells (day 0) and tacrolimus (2 mg/kg/day; days 0-12), On day 15, enhanced numbers of donor (IA(b+)) cells were detected in the thymi and spleens of FL-BM recipients. Tacrolimus markedly enhanced microchimerism, which declined as a function of time. Ex vivo splenocyte proliferative and CTL responses and Th1 cytokine (IFN-gamma) production in response to donor alloantigens were augmented by FL-BM infusion, but reduced by tacrolimus, Systemic infusion of purified FL-BM immature DC, equivalent in number to that in corresponding whole BM, confirmed their capacity to sensitize, rather than tolerize, recipient T cells in vivo. In vitro, tacrolimus suppressed GM-CSF-stimulated growth of myeloid DC from normal BM much more effectively than from FL-BM without affecting MHC class D or costimulatory molecule expression. infusion of normal B10 BM cells at the time of transplant prolonged C3H heart allograft survival, whereas FL-BM cells did not. A therapeutic effect of tacrolimus on graft survival was observed in combination with normal, but not FL-BM cells, These Endings suggest the need for alternative immunosuppressive strategies to calcineurin inhibition to enable the engraftment, survival, and immunomodulatory function of FL-enhanced, immature donor DC.
引用
收藏
页码:226 / 237
页数:12
相关论文
共 61 条
  • [1] Antonysamy MA, 1998, J IMMUNOL, V160, P4106
  • [2] Antonysamy MA, 1999, J IMMUNOL, V162, P577
  • [3] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [4] USE OF CRYOPRESERVED DONOR BONE-MARROW IN CADAVER KIDNEY ALLOGRAFT RECIPIENTS
    BARBER, WH
    DIETHELM, AG
    LASKOW, DA
    DEIERHOI, MH
    JULIAN, BA
    CURTIS, JJ
    [J]. TRANSPLANTATION, 1989, 47 (01) : 66 - 71
  • [5] Dendritic cells
    Bell, D
    Young, JW
    Banchereau, J
    [J]. ADVANCES IN IMMUNOLOGY, VOL. 72, 1999, 72 : 255 - 324
  • [6] ACTIVELY ACQUIRED TOLERANCE OF FOREIGN CELLS
    BILLINGHAM, RE
    BRENT, L
    MEDAWAR, PB
    [J]. NATURE, 1953, 172 (4379) : 603 - 606
  • [7] QUANTITATIVE STUDIES ON TISSUE TRANSPLANTATION IMMUNITY .3. ACTIVELY ACQUIRED TOLERANCE
    BILLINGHAM, RE
    BRENT, L
    MEDAWAR, PB
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1956, 239 (666) : 357 - 412
  • [8] BLAZAR BR, 1988, BLOOD, V71, P320
  • [9] BONHAM CA, 1997, CURR OPIN ORGAN TRAN, V2, P23
  • [10] Hematologic effects of flt3 ligand in vivo in mice
    Brasel, K
    McKenna, HJ
    Morrissey, PJ
    Charrier, K
    Morris, AE
    Lee, CC
    Williams, DE
    Lyman, SD
    [J]. BLOOD, 1996, 88 (06) : 2004 - 2012